These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
72 related items for PubMed ID: 1666665
1. [Mechanism of action of adenosine on intracellular calcium and platelet aggregation]. Feoktistov IA, Pol S, Khollister AS, Robertson D, Biadzhoni I. Kardiologiia; 1991 Nov; 31(11):76-9. PubMed ID: 1666665 [Abstract] [Full Text] [Related]
2. Role of cyclic AMP in adenosine inhibition of intracellular calcium rise in human platelets. Comparison of adenosine effects on thrombin- and epinephrine-induced platelet stimulation. Feoktistov IA, Paul S, Hollister AS, Robertson D, Biaggioni I. Am J Hypertens; 1992 Jun; 5(6 Pt 2):147S-153S. PubMed ID: 1321639 [Abstract] [Full Text] [Related]
3. Adenosine inhibits the rise in intracellular calcium and platelet aggregation produced by thrombin: evidence that both effects are coupled to adenylate cyclase. Paul S, Feoktistov I, Hollister AS, Robertson D, Biaggioni I. Mol Pharmacol; 1990 Jun; 37(6):870-5. PubMed ID: 2359405 [Abstract] [Full Text] [Related]
4. The thienopyridine ticlopidine selectively prevents the inhibitory effects of ADP but not of adrenaline on cAMP levels raised by stimulation of the adenylate cyclase of human platelets by PGE1. Gachet C, Cazenave JP, Ohlmann P, Bouloux C, Defreyn G, Driot F, Maffrand JP. Biochem Pharmacol; 1990 Dec 15; 40(12):2683-7. PubMed ID: 2175608 [Abstract] [Full Text] [Related]
5. Toborinone and olprinone, phosphodiesterase III inhibitors, inhibit human platelet aggregation due to the inhibition of both calcium release from intracellular stores and calcium entry. Kageyama K, Mizobe T, Nozuchi S, Hiramatsu N, Nakajima Y, Aoki H. J Anesth; 2004 Dec 15; 18(2):107-12. PubMed ID: 15127258 [Abstract] [Full Text] [Related]
6. Antiplatelet effect of sanguinarine is correlated to calcium mobilization, thromboxane and cAMP production. Jeng JH, Wu HL, Lin BR, Lan WH, Chang HH, Ho YS, Lee PH, Wang YJ, Wang JS, Chen YJ, Chang MC. Atherosclerosis; 2007 Apr 15; 191(2):250-8. PubMed ID: 16797553 [Abstract] [Full Text] [Related]
7. Direct inhibitory mechanisms of halothane on human platelet aggregation. Kohro S, Yamakage M. Anesthesiology; 1996 Jul 15; 85(1):96-106; discussion 30A. PubMed ID: 8694388 [Abstract] [Full Text] [Related]
8. In vitro adrenaline and collagen-induced mobilization of platelet calcium and its inhibition by naftopidil, doxazosin and nifedipine. Alarayyed NA, Cooper MB, Prichard BN, Betteridge DJ, Smith CC. Br J Clin Pharmacol; 1997 Apr 15; 43(4):415-20. PubMed ID: 9146854 [Abstract] [Full Text] [Related]
9. Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation. Vigne P, Hechler B, Gachet C, Breittmayer JP, Frelin C. Biochem Biophys Res Commun; 1999 Mar 05; 256(1):94-7. PubMed ID: 10066429 [Abstract] [Full Text] [Related]
10. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP. Maurice DH, Haslam RJ. Mol Pharmacol; 1990 May 05; 37(5):671-81. PubMed ID: 2160060 [Abstract] [Full Text] [Related]
11. Cyclic nucleotide phosphodiesterase inhibitors prevent aggregation of human platelets by raising cyclic AMP and reducing cytoplasmic free calcium mobilization. Lanza F, Beretz A, Stierlé A, Corre G, Cazenave JP. Thromb Res; 1987 Mar 01; 45(5):477-84. PubMed ID: 3035738 [Abstract] [Full Text] [Related]
12. Octimibate inhibition of platelet aggregation: stimulation of adenylate cyclase through prostacyclin receptor activation. Seiler S, Brassard CL, Arnold AJ, Meanwell NA, Fleming JS, Keely SL. J Pharmacol Exp Ther; 1990 Dec 01; 255(3):1021-6. PubMed ID: 2175792 [Abstract] [Full Text] [Related]
13. Inhibitory effect of GBH on platelet aggregation through inhibition of intracellular Ca2+ mobilization in activated human platelets. Park WH, Kim HK, Nam KS, Shon YH, Jeon BH, Moon SK, Kim MG, Kim CH. Life Sci; 2004 Nov 05; 75(25):3063-76. PubMed ID: 15474558 [Abstract] [Full Text] [Related]
14. Cordycepin (3'-deoxyadenosine) inhibits human platelet aggregation in a cyclic AMP- and cyclic GMP-dependent manner. Cho HJ, Cho JY, Rhee MH, Park HJ. Eur J Pharmacol; 2007 Mar 08; 558(1-3):43-51. PubMed ID: 17229422 [Abstract] [Full Text] [Related]
15. Cilostazol and dipyridamole synergistically inhibit human platelet aggregation. Liu Y, Cone J, Le SN, Fong M, Tao L, Shoaf SE, Bricmont P, Czerwiec FS, Kambayashi J, Yoshitake M, Sun B. J Cardiovasc Pharmacol; 2004 Aug 08; 44(2):266-73. PubMed ID: 15243309 [Abstract] [Full Text] [Related]
16. Splitomicin suppresses human platelet aggregation via inhibition of cyclic AMP phosphodiesterase and intracellular Ca++ release. Liu FC, Liao CH, Chang YW, Liou JT, Day YJ. Thromb Res; 2009 Jun 08; 124(2):199-207. PubMed ID: 19327818 [Abstract] [Full Text] [Related]
17. H2O2-induced platelet aggregation and increase in intracellular Ca2+ concentration are blocked by inhibitors of intracellular signaling. Loiko EN, Samal AB, Shulyakovskaya SM. Biochemistry (Mosc); 2003 Nov 08; 68(11):1210-6. PubMed ID: 14640963 [Abstract] [Full Text] [Related]
18. Cross-talk between adenosine and the oxatriazole derivative GEA 3175 in platelets. Asplund Persson A, Zalavary S, Lindström E, Whiss PA, Bengtsson T, Grenegård M. Eur J Pharmacol; 2005 Jul 11; 517(3):149-57. PubMed ID: 15963495 [Abstract] [Full Text] [Related]
19. Cloricromene inhibits the activation of human platelets by ADP alone or in combination with adrenaline. Del Maschio A, Bazzoni G, Zatta A, Chen ZM, Dejana E, Prosdocimi M. Eur J Pharmacol; 1990 Oct 23; 187(3):541-5. PubMed ID: 2073928 [Abstract] [Full Text] [Related]
20. Mode of action of 2-(diethylamino)-7-ethoxychromone on human platelets. Leoncini G, Maresca M, Colao C, Buzzi E, Mazzei M. Cell Biochem Funct; 1991 Apr 23; 9(2):79-85. PubMed ID: 1718622 [Abstract] [Full Text] [Related] Page: [Next] [New Search]